APRE - Company ID 0001781983
The table below shows Aprea Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $37.85M | $41.23M | $46.47M | $13.72M | $16.53M | $19.28M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $38.44M |
| $41.91M |
| $47.25M |
| $13.94M |
| $16.93M |
| $19.83M |
| Property, plant & equipment | $62.44K | $64.03K | $54.38K | $65.24K | $70.67K | $76.09K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $38.81M | $42.29M | $47.61M | $14.32M | $17.31M | $20.22M |
| Accounts payable | $1.26M | $935.14K | $2.94M | $641.32K | $1.20M | $1.28M |
| Total current liabilities | $3.97M | $3.09M | $5.30M | $2.68M | $3.17M | $3.36M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$345.33M | -$340.52M | -$336.93M | -$331.19M | -$328.21M | -$324.97M |
| Total equity | $34.11M | $38.47M | $41.59M | $10.91M | $13.41M | $15.55M |